Intersect ENT Inc (NASDAQ:XENT)

37.70
Delayed Data
As of Feb 16
 -0.10 / -0.26%
Today’s Change
12.50
Today|||52-Week Range
38.30
+16.36%
Year-to-Date
No recent news for Intersect ENT Inc.

Today’s Trading

Previous close37.80
Today’s open37.70
Day’s range37.60 - 38.30
Volume153,127
Average volume (3 months)265,116
Market cap$1.1B
Data as of 4:00pm ET, 02/16/2018

Growth & Valuation

Earnings growth (last year)+12.75%
Earnings growth (this year)+28.82%
Earnings growth (next 5 years)-18.10%
Revenue growth (last year)+30.11%
P/E ratioNM
Price/Sales4.37
Price/Book9.45

Competitors

 Today’s
change
Today’s
% change
LMNXLuminex Corp-0.02-0.10%
CSIICardiovascular Syste...-0.01-0.04%
KTWOK2M Group Holdings I...+0.13+0.68%
ANIKAnika Therapeutics I...+1.13+1.90%
Data as of 4:00pm ET, 02/16/2018

Financials

Next reporting dateFebruary 28, 2018
EPS forecast (this quarter)-$0.18
Annual revenue (last year)$78.7M
Annual profit (last year)-$25.2M
Net profit margin-32.05%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Lisa D. Earnhardt
COO, Senior VP-Research &
Development
Richard E. Kaufman
Corporate headquarters
Menlo Park, California

Forecasts